ctdh20250407_1512g.htm

15-12G 1 ctdh20250407_1512g.htm FORM 15-12G ctdh20250407_1512g.htm

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

FORM 15

CERTIFICATION AND NOTICE OF TERMINATION OF REGISTRATION UNDER SECTION 12(g) OF THE SECURITIES EXCHANGE ACT OF 1934 OR SUSPENSION OF DUTY TO FILE REPORTS UNDER SECTIONS 13 AND 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934.

Commission File Number: 001-39780

CYCLO THERAPEUTICS, INC.

(Exact name of registrant as specified in its charter)

6714 NW 16th Street, Suite B

Gainesville, Florida 32653

(386) 418-8060

(Address, including zip code, and telephone number, including area code,

of registrant’s principal executive offices)

Title of each class	Trading Symbol(s)	Name of each exchange on which registered
Common Stock, par value $.0001 per share	CYTH	The Nasdaq Stock Market LLC
Warrants to purchase Common Stock	CYTHW	The Nasdaq Stock Market LLC

(Title of each class of securities covered by this Form)

None

(Titles of all other classes of securities for which a duty to file reports under section 13(a) or 15(d) remains)

Please place an X in the box(es) to designate the appropriate rule provision(s) relied upon to terminate or suspend the duty to file reports:

	Rule 12g-4(a)(1)	☒
	Rule 12g-4(a)(2)	☐
	Rule 12h-3(b)(1)(i)	☒
	Rule 12h-3(b)(1)(ii)	☐
	Rule 15d-6	☐
	Rule 15d-22(b)	☐

Approximate number of holders of record as of the certification or notice date of the Common Stock: 1

Approximate number of holders of record as of the certification or notice date of the Warrants: None

Pursuant to the requirements of the Securities Exchange Act of 1934, Cyclo Therapeutics, Inc. has caused this certification/notice to be signed on its behalf by the undersigned duly authorized person.

	CYCLO THERAPEUTICS, INC.

Date: April 7, 2025	By:	/s/ N. Scott Fine
	Name:	N. Scott Fine
	Title:	Chief Executive Officer

SEC Form 15-12G filed by Cyclo Therapeutics Inc.